sirolimus

Product NDC
65841-772
11-digit product format
658410772
Labeler code
65841
Product ID
65841-772_7e6e294d-cf29-40e2-91e1-9693fdcd6b6c
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
sirolimus
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
Zydus Lifesciences Limited
Application
ANDA201676
Marketing category
ANDA
Marketing start
2023-02-16
Substance
SIROLIMUS
Active strength
1 mg/1
Pharmacologic classes
Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
sirolimus
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
SIROLIMUS1 mg/1

Harmonized Identifiers#

Field, Values table
FieldValues
UniiW36ZG6FT64
Rxcui349208, 360110, 905158

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
65841-772-0165841077201100 TABLET, FILM COATED in 1 BOTTLE (65841-772-01) 2023-02-16NoNoHistorical
65841-772-776584107727710 BLISTER PACK in 1 CARTON (65841-772-77) / 10 TABLET, FILM COATED in 1 BLISTER PACK (65841-772-30) 10 blister pack2023-02-16NoNoHistorical